C140H250N30O9 — CID 159913103
N-(azetidin-3-yl)-6-tert-butyl-2-(4-ethylpiperazin-1-yl)pyrimidin-4-amine;N-(azetidin-3-yl)-6-tert-butyl-2-propan-2-yloxypyrimidin-4-amine;6-tert-butyl-2-methoxy-N-(oxetan-3-yl)pyrimidin-4-amine;6-tert-butyl-2-(2-methylpropyl)-N-(oxetan-3-yl)pyrimidin-4-amine;1-[4-[4-tert-butyl-6-(oxetan-3-ylamino)pyrimidin-2-yl]piperazin-1-yl]-2-methylpropan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]butan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]-3-methylbutan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]-2-methylpropan-1-one;methane (PubChem CID 159913103) has the molecular formula C140H250N30O9 and a molecular weight of 2497.74 g/mol. Its IUPAC name is N-(azetidin-3-yl)-6-tert-butyl-2-(4-ethylpiperazin-1-yl)pyrimidin-4-amine;N-(azetidin-3-yl)-6-tert-butyl-2-propan-2-yloxypyrimidin-4-amine;6-tert-butyl-2-methoxy-N-(oxetan-3-yl)pyrimidin-4-amine;6-tert-butyl-2-(2-methylpropyl)-N-(oxetan-3-yl)pyrimidin-4-amine;1-[4-[4-tert-butyl-6-(oxetan-3-ylamino)pyrimidin-2-yl]piperazin-1-yl]-2-methylpropan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]butan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]-3-methylbutan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]-2-methylpropan-1-one;methane.
| Compound Name | N-(azetidin-3-yl)-6-tert-butyl-2-(4-ethylpiperazin-1-yl)pyrimidin-4-amine;N-(azetidin-3-yl)-6-tert-butyl-2-propan-2-yloxypyrimidin-4-amine;6-tert-butyl-2-methoxy-N-(oxetan-3-yl)pyrimidin-4-amine;6-tert-butyl-2-(2-methylpropyl)-N-(oxetan-3-yl)pyrimidin-4-amine;1-[4-[4-tert-butyl-6-(oxetan-3-ylamino)pyrimidin-2-yl]piperazin-1-yl]-2-methylpropan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]butan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]-3-methylbutan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]-2-methylpropan-1-one;methane |
|---|---|
| PubChem CID | 159913103 |
| Molecular Formula | C140H250N30O9 |
| Molecular Weight | 2497.74 g/mol |
| Exact Mass | 2496.00 |
| IUPAC Name | N-(azetidin-3-yl)-6-tert-butyl-2-(4-ethylpiperazin-1-yl)pyrimidin-4-amine;N-(azetidin-3-yl)-6-tert-butyl-2-propan-2-yloxypyrimidin-4-amine;6-tert-butyl-2-methoxy-N-(oxetan-3-yl)pyrimidin-4-amine;6-tert-butyl-2-(2-methylpropyl)-N-(oxetan-3-yl)pyrimidin-4-amine;1-[4-[4-tert-butyl-6-(oxetan-3-ylamino)pyrimidin-2-yl]piperazin-1-yl]-2-methylpropan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]butan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]-3-methylbutan-1-one;1-[4-[(4-tert-butyl-2-pyridinyl)amino]piperidin-1-yl]-2-methylpropan-1-one;methane |
| SMILES | C.C.C.C.C.C.C.C.CC(C)C(=O)N1CCC(Nc2cc(C(C)(C)C)ccn2)CC1.CC(C)C(=O)N1CCN(c2nc(NC3COC3)cc(C(C)(C)C)n2)CC1.CC(C)CC(=O)N1CCC(Nc2cc(C(C)(C)C)ccn2)CC1.CC(C)Cc1nc(NC2COC2)cc(C(C)(C)C)n1.CC(C)Oc1nc(NC2CNC2)cc(C(C)(C)C)n1.CCCC(=O)N1CCC(Nc2cc(C(C)(C)C)ccn2)CC1.CCN1CCN(c2nc(NC3CNC3)cc(C(C)(C)C)n2)CC1.COc1nc(NC2COC2)cc(C(C)(C)C)n1 |
| InChI | InChI=1S/C19H31N5O2.C19H31N3O.2C18H29N3O.C17H30N6.C15H25N3O.C14H24N4O.C12H19N3O2.8CH4/c1-13(2)17(25)23-6-8-24(9-7-23)18-21-15(19(3,4)5)10-16(22-18)20-14-11-26-12-14;1-14(2)12-18(23)22-10-7-16(8-11-22)21-17-13-15(6-9-20-17)19(3,4)5;1-13(2)17(22)21-10-7-15(8-11-21)20-16-12-14(6-9-19-16)18(3,4)5;1-5-6-17(22)21-11-8-15(9-12-21)20-16-13-14(7-10-19-16)18(2,3)4;1-5-22-6-8-23(9-7-22)16-20-14(17(2,3)4)10-15(21-16)19-13-11-18-12-13;1-10(2)6-13-17-12(15(3,4)5)7-14(18-13)16-11-8-19-9-11;1-9(2)19-13-17-11(14(3,4)5)6-12(18-13)16-10-7-15-8-10;1-12(2,3)9-5-10(13-8-6-17-7-8)15-11(14-9)16-4;;;;;;;;/h10,13-14H,6-9,11-12H2,1-5H3,(H,20,21,22);6,9,13-14,16H,7-8,10-12H2,1-5H3,(H,20,21);6,9,12-13,15H,7-8,10-11H2,1-5H3,(H,19,20);7,10,13,15H,5-6,8-9,11-12H2,1-4H3,(H,19,20);10,13,18H,5-9,11-12H2,1-4H3,(H,19,20,21);7,10-11H,6,8-9H2,1-5H3,(H,16,17,18);6,9-10,15H,7-8H2,1-5H3,(H,16,17,18);5,8H,6-7H2,1-4H3,(H,13,14,15);8*1H4 |
| InChIKey | NXKVRILEUPYANH-UHFFFAOYSA-N |
| XLogP | 25.45 |
| TPSA | 424.98 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 179 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2497.74 |
| LogP ≤ 5 | 25.45 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 35 |